The annual ATS Women's Forum recognizes the achievements and supports the advancement of women in pulmonary, critical care, and sleep medicine and research. The forum provides a valuable opportunity for women to find value in the inspirational messages and career insights the speakers share. This year Yolanda Mageto, MD, MPH, ATSF will discuss their experiences during the forum. The Elizabeth A. Rich, MD Award, recognizing outstanding contributions to the advancement of women in pulmonary medicine, will be presented at this year’s Women’s Forum.

Dr. Mageto is a pulmonary critical care specialist with nationally recognized expertise in interstitial lung disease (ILD) and is currently the Medical Director of Interstitial Lung Disease at Baylor University Medical Center at Dallas. Dr. Mageto attended medical school at Washington University in St. Louis, Missouri and completed her residency and training at University of Texas Southwestern and her fellowship in pulmonary and critical care medicine at the University of Washington in Seattle with a focus in ILD. Since that time, she has held faculty positions at the University of Washington Seattle, University of Texas Southwestern and most recently University of Vermont where she rose to the rank of full Professor. Dr. Mageto is a clinician, educator and researcher involved in multiple idiopathic pulmonary fibrosis/ILD trials over the last 20 years including collaborations with investigators from other centers in sarcoidosis related lung disease. She remains actively involved in the total care and management of her patients. Dr. Mageto is dedicated to the development of a Comprehensive Integrated Interstitial Lung disease program optimizing delivery of care to patients with interstitial lung disease in the Dallas Fort Worth Area.

Yolanda has actively contributed to the ATS in various leadership roles, including chairing the Membership and Planning and Evaluation Committees, serving on the Board of Directors, and participating in numerous other committees. With a pragmatic and inclusive leadership style, she has helped drive key initiatives to diversify the ATS, enhance member engagement, and strengthen its overall impact in the field of respiratory medicine.

The forum is organized and presented by the ATS Membership Committee.

ATS Thanks Johnson & Johnson, Sanofi | Regeneron, and Genentech USA for their generous support of the ATS 2025 Women's Forum

Pre-registration and an additional fee are required.
$40 Member/Non-Member